Antibodies to GAD65 and peripheral nerve function in the DCCT

Area of Science:

• Immunology
• Endocrinology
• Neurology

Background:

• Antibodies to glutamic acid decarboxylase 65 (GAD65Ab) have been suggested to associate with neuropathy in Type 1 diabetes.
• Previous small studies indicated a potential link, necessitating larger investigations.

Purpose of the Study:

• To confirm the association between GAD65Ab and neuropathy in Type 1 diabetes.
• To investigate correlations between autoantibodies, C-peptide, and glycemic control.
• To explore epitope-specific binding patterns in relation to neuropathy.

Main Methods:

• Measured GAD65Ab, GAD65Ab epitopes, and IA-2Ab in 511 Type 1 diabetes patients from the DCCT.
• Assessed neuropathy using electrophysiological, autonomic, and clinical evaluations.
• Matched controls based on C-peptide response to a standardized meal.

Main Results:

• GAD65Ab index correlated with HbA1c in adult participants at baseline only.
• Adults with poor glycemic control had higher GAD65Ab and lower C-peptide levels.
• No significant difference in GAD65Ab index was found between neuropathy patients and matched controls.
• Epitope analysis revealed decreased binding to multiple epitopes in patients with neuropathy.

Conclusions:

• The study did not confirm a significant association between GAD65Ab and clinical neuropathy in Type 1 diabetes.
• Glycemic control and C-peptide levels showed some correlations with GAD65Ab in adults.
• Epitope-specific binding patterns may offer insights into the immunopathogenesis of neuropathy in diabetes.